Private EquityRIA · CRD 315669SEC-RegisteredPrivate Fund Adviser

Updated:

Kain Capital

Kain Capital is an SEC-registered investment adviser in New York, NY, registered since 2022. The firm manages approximately $802 million in regulatory assets.

Kain Capital logo

Kain Capital

Kain Capital is an SEC-registered investment adviser in New York, NY, registered since 2022. The firm manages approximately $802 million in regulatory assets. It has 14 employees and 8 investment advisers.

General information

Firm type

Private Equity

Year founded

2014

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, NY, United States

Principals

Kunal Kain

Founder & Managing Partner

Sector focus

Enterprise SoftwareDigital HealthFinTechAI/ML

Frequently asked questions

What is Kain Capital's investment strategy?

Kain Capital pursues control-oriented growth and buyout investments in the lower middle market, focusing on technology-enabled business services and healthcare. The firm targets founder-led companies with $5 million to $25 million in revenue and applies an operating-intensive model — installing management systems, refining go-to-market approaches, and funding follow-on acquisitions. The strategy is concentrated and sector-specific rather than broadly opportunistic.

How does Kain Capital source deals?

Kain sources primarily through domain-specialist intermediaries, sector conferences, and direct outreach to founder-owners in targeted verticals. The firm's operational reputation in healthcare IT and compliance software creates a referral channel from executives who have worked with Kain-backed companies. The firm does not run a broad auction-process strategy, preferring proprietary and limited-process situations where operational complexity suppresses competition.

What sectors does Kain Capital explicitly avoid?

Kain does not invest in commodity-manufacturing, natural resources, or capital-intensive infrastructure. The firm's thesis confines it to asset-light, technology-enabled services and healthcare companies where operational intervention — not balance-sheet engineering — drives returns. Hard-tech, biotech, and consumer-facing retail are absent from the firm's disclosed portfolio activity.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More New York Private Equity profiles